- Multiple Sclerosis
- Rhinitis, Allergic, Perennial
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
If you have a relapsing form of MS, screening EDSS score below 6.0, at least one clinical relapse in the 12 months before screening, and have failed prior treatment with beta-interferon, you may qualify for this study.
The research site is in Nashville, Tenn.
Rhinitis, Allergic, Perennial
If you have a history of seasonal allergic rhinitis symptoms and a positive skin test of at least one grass allergen, you may qualify for this study. Women of childbearing potential must use a medically acceptable form of contraception.
The research site is in Orange, Calif.
If you are at least 18, and are able to provide at least four urine samples in a two-week period -- at least one of which is positive for methamphetamine -- you may qualify for this study.
The research site is in Lake Charles, La.
Copyright 2008 CenterWatch. All rights reserved.